Published in Eur Respir J on March 29, 2010
Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol (2014) 1.72
A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG. Eur J Immunol (2011) 1.04
Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues. Immunology (2015) 0.85
Impact of smoking on dendritic cell phenotypes in the airway lumen of patients with COPD. Respir Res (2014) 0.83
Characterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung. PLoS One (2016) 0.79
Cigarette Smoke Decreases the Maturation of Lung Myeloid Dendritic Cells. PLoS One (2016) 0.78
Imbalance of dendritic cell co-stimulation in COPD. Respir Res (2015) 0.78
Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung. Front Immunol (2016) 0.77
Dendritic Cell Subsets in Oral Mucosa of Allergic and Healthy Subjects. PLoS One (2016) 0.75
Neuropilin-1 Is Expressed on Lymphoid Tissue Residing LTi-like Group 3 Innate Lymphoid Cells and Associated with Ectopic Lymphoid Aggregates. Cell Rep (2017) 0.75
Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection. Front Immunol (2016) 0.75
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.09
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13
Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med (1999) 2.03
The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med (2001) 1.96
Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax (1996) 1.94
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax (2001) 1.94
Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J (1996) 1.91
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J (2001) 1.88
Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis (1993) 1.87
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J (2010) 1.86
SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA. Mol Cell Biol (2000) 1.84
Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J (2005) 1.81
Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax (1991) 1.79
Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax (2005) 1.76
Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.73
Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J (1999) 1.62
Comparison of corridor and treadmill walking in patients with severe chronic obstructive pulmonary disease. Phys Ther (1990) 1.61
Long-term outcome of pulmonary rehabilitation in patients with COPD. Chest (1997) 1.60
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr (2000) 1.58
The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J (2006) 1.56
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol (1995) 1.56
Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem (2001) 1.55
Postoperative pulmonary function abnormalities after coronary artery bypass surgery. Respir Med (1992) 1.53
The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant (2008) 1.52
Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J (2007) 1.52
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3. Eur Respir J (2011) 1.51
Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1998) 1.51
Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) (1999) 1.49
Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1998) 1.47
Lymphocytic bronchiolitis after lung transplantation is associated with daily changes in air pollution. Am J Transplant (2012) 1.47
Osteitic bone in recalcitrant chronic rhinosinusitis. Rhinology (2011) 1.44
Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation. Am J Transplant (2014) 1.43
Evaluation of quality of life in sarcoidosis patients. Respir Med (1998) 1.40
Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.38
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.38
Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J (2011) 1.37
Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med (1998) 1.36
Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J (1994) 1.30
Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol (1999) 1.28
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J (1997) 1.26
Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med (1995) 1.25
The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J (1999) 1.25
Lymphoid follicles in (very) severe COPD: beneficial or harmful? Eur Respir J (2009) 1.25
dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster. Exp Cell Res (2001) 1.24
Decreased FOXP3 protein expression in patients with asthma. Allergy (2009) 1.22
Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.22
Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1991) 1.21
Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol (2000) 1.20
Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18
Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.16
Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study. Eur Respir J (2009) 1.16
Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol (1999) 1.16
Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med (1996) 1.15
Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis. Allergy (2010) 1.14
Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol (2000) 1.14
Adverse effects of the indoor environment on respiratory health in primary school children. Environ Res (1995) 1.14
Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant (2006) 1.13
Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1991) 1.13
The effects of 5-HT on cholinergic contraction in human airways in vitro. Eur Respir J (1999) 1.13
Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. Eur Respir J (2009) 1.12
Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Respir J (2000) 1.11
Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: no role for tumor necrosis factor-alpha and infiltrating neutrophils. Am J Respir Cell Mol Biol (2001) 1.10
Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice. Clin Exp Allergy (2007) 1.09
The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia. Am J Clin Nutr (1995) 1.07
Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis (1991) 1.06
Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr (1999) 1.06
How epithelial cells detect danger: aiding the immune response. Allergy (2008) 1.06
Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.04
Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr (1998) 1.04
Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur Respir J (2006) 1.03
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J (2008) 1.03
Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J (1997) 1.01
Interval versus continuous training in patients with severe COPD: a randomized clinical trial. Eur Respir J (1999) 1.01
Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.01
Exercise-induced lactate increase in relation to muscle substrates in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.01
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy (2007) 1.01
Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Eur Respir J (2008) 1.00
Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int Arch Allergy Immunol (1995) 1.00
Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.00
Chronic obstructive pulmonary disease: evaluation with spirometrically controlled CT lung densitometry. Radiology (1994) 0.99
Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol (2001) 0.99
Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 0.99
Murine models of COPD. Pulm Pharmacol Ther (2005) 0.99
Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Radiother Oncol (1998) 0.98